Nations Financial Group Inc, Horizon Therapeutics Public LTD CO Transaction History

Nations Financial Group Inc,

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $388,250 - $452,891	-4,030 Reduced 37.04%	6,849 $704,000
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $198,542 - $209,975	1,850 Added 20.49%	10,879 $1.19 Million
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $187,170 - $341,400	-3,000 Reduced 24.94%	9,029 $1.03 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $71,528 - $102,789	-1,214 Reduced 9.17%	12,029 $744,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $341,658 - $500,697	4,303 Added 48.13%	13,243 $1.06 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $233,593 - $296,816	2,703 Added 43.34%	8,940 $941,000
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $97,081 - $118,111	985 Added 18.75%	6,237 $672,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $482,711 - $579,663	5,252 New	5,252 $575,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

Stay updated on Nations Financial Group Inc, with notifications on news.